Balt USA, LLC: FDA clearances and approvals

Balt USA, LLC has 19 FDA 510(k) clearances (first 2018, latest 2026), plus 1 PMA decision, across 9 product codes in 2 review panels. Median 510(k) review time: 143 days. Since 2017 its median was 143 days, against 114 days for all cleared 510(k)s in the same product codes. openFDA lists 8 product recalls by a recalling firm named Balt USA, LLC. It is the industry lead sponsor of 1 device clinical trial on ClinicalTrials.gov.

510(k) clearances per year

YearClearancesMedian review days
2018137
20192166
2020125
20211163
20222150
20231191
20244168
2025450
20263108

Review time against the same product codes

Since 2017, Balt USA, LLC's cleared 510(k)s took a median 143 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 114 days.

Top product codes

Product codeDeviceSubmissions510(k) clearances
QJPCatheter, Percutaneous, Neurovasculature66
HCGDevice, Neurovascular Embolization55
KRACatheter, Continuous Flush22
NRYCatheter, Thrombus Retriever22
DQYCatheter, Percutaneous11
KRDDevice, Vascular, For Promoting Embolization11
MJNCatheter, Intravascular Occluding, Temporary11
MOFGuide, Wire, Catheter, Neurovasculature11
SGUNeurovascular Liquid Embolic Agent10

Review panels

Most recent Balt USA, LLC 510(k) clearances

510(k)DeviceProduct codeDecision dateReview days
K260199SLIM MicrocatheterQJP2026-07-13172
K254223Next Generation 088 CatheterQJP2026-04-16108
K254221Optima Coil System (OptiOne Coil System)HCG2026-01-2729
K252569Carrier XL Delivery CatheterQJP2025-10-2269
K252700Optima Coil System (Optima Packing Coil System)HCG2025-09-2630
K243948Raptor Aspiration Catheter; Balt Aspiration Tubing SetNRY2025-06-03162
K251383Prestige Coil System (Prestige Packing Line Extension)KRD2025-05-3028
K242376Next Generation Access PlatformQJP2024-12-30143
K242582Optima Coil System (OptiBlock Line Extension)HCG2024-09-2728
K234083Next Generation Aspiration Catheter; Balt Aspiration Tubing SetNRY2024-07-02193

9 earlier clearances. See the full list in Caduvo.

PMA and De Novo decisions

NumberPathwayDeviceDecision date
P250009PMASQUID Liquid Embolic Agent (LEA)2026-01-30

Recalls

8 product recalls in 6 recall events; 8 initiated in the last five years. Most recent: 2025-09-25.

Recalling firms are matched to this company by name only (same normalization as the applicant), so related entities that recall under another name are not counted.

Device clinical trials

Balt USA, LLC is the industry lead sponsor of 1 device studies on ClinicalTrials.gov (0 active or recruiting). Most recent:

Frequently asked questions

How many FDA 510(k) clearances does Balt USA, LLC have?

Balt USA, LLC has 19 FDA 510(k) clearances (first 2018, latest 2026), plus 1 PMA decision, across 9 product codes in 2 review panels.

How long does FDA take to clear Balt USA, LLC's 510(k)s?

The median time from FDA receipt to decision across Balt USA, LLC's cleared 510(k)s is 143 days. Since 2017: 143 days, versus 114 days for all cleared 510(k)s in the same product codes.

What devices does Balt USA, LLC make?

Its most frequent FDA product codes are QJP (Catheter, Percutaneous, Neurovasculature, 6); HCG (Device, Neurovascular Embolization, 5); KRA (Catheter, Continuous Flush, 2).

Has Balt USA, LLC had device recalls?

openFDA lists 8 product recalls in 6 recall events by a recalling firm whose name matches Balt USA, LLC; the most recent began 2025-09-25. Recall firm names are matched by name, so related entities filing under other names are not included.

Next steps

Data from openFDA (510(k), PMA, De Novo, device recalls), ClinicalTrials.gov and SEC company tickers. Companies are grouped by FDA applicant name with punctuation and legal suffixes removed. Review days run from FDA receipt to decision. Not regulatory advice.

All FDA device companies · FDA product code lookup